comparemela.com
Home
Live Updates
New Treatment Options - Breaking News
Pages:
4
5
6
7
8
9
10
Latest Breaking News On - New treatment options - Page 3 : comparemela.com
Relapsed/Refractory DLBCL: Therapeutic Options in the Third Line Setting
Focusing their discussion on therapeutic options for patients with R/R DLBCL, in the third line and beyond setting.
New treatment options
Sequencing therapeutic choices
Therapeutic options
Third line
Diffuse largeb cell lymphoma
Dlbcl treatments
Dlbcl therapies
Dlbcl unmet needs
Clinical Perspectives of CAR T in R/R Diffuse Large B-Cell Lymphoma
Experts share clinical perspectives on the use of CAR T for patients with DLBCL, in the R/R setting.
New treatment options
Sequencing therapeutic choices
Diffuse largeb cell lymphoma
Dlbcl treatments
Dlbcl therapies
Dlbcl unmet needs
The Role of CAR T-Cell Therapy in R/R DLBCL
Centering discussion on the role of CAR T-cell therapy for patients with R/R DLBCL.
New treatment options
Sequencing therapeutic choices
Cell therapy
Diffuse largeb cell lymphoma
Dlbcl treatments
Dlbcl therapies
Dlbcl unmet needs
Real-World Outcomes of Tafasitamab-Lenalidomide for Patients with R/R DLBCL
Panelists consider real-world outcomes for treating patients with tafasitamab-lenalidomide for R/R DLBCL.
New treatment options
Sequencing therapeutic choices
World outcomes
Diffuse largeb cell lymphoma
Dlbcl treatments
Dlbcl therapies
Dlbcl unmet needs
Tafasitamab and Lenalidomide for R/R DLBCL
A comprehensive overview of tafasitamab plus lenalidomide for patients with relapsed/refractory DLBCL, highlighting data updates and the impact on clinical practice.
New treatment options
Sequencing therapeutic choices
Diffuse largeb cell lymphoma
Dlbcl treatments
Dlbcl therapies
Dlbcl unmet needs
vimarsana © 2020. All Rights Reserved.